Baird Financial Group’s Ionis Pharmaceuticals IONS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-6,696
| Closed | -$290K | – | 1799 |
|
|
2024
Q1 | $290K | Buy |
6,696
+7
| +0.1% | +$303 | ﹤0.01% | 1563 |
|
|
2023
Q4 | $338K | Sell |
6,689
-85
| -1% | -$4.3K | ﹤0.01% | 1476 |
|
|
2023
Q3 | $307K | Buy |
6,774
+185
| +3% | +$8.39K | ﹤0.01% | 1492 |
|
|
2023
Q2 | $270K | Sell |
6,589
-194
| -3% | -$7.96K | ﹤0.01% | 1535 |
|
|
2023
Q1 | $242K | Sell |
6,783
-110
| -2% | -$3.93K | ﹤0.01% | 1563 |
|
|
2022
Q4 | $261K | Buy |
6,893
+121
| +2% | +$4.58K | ﹤0.01% | 1506 |
|
|
2022
Q3 | $300K | Sell |
6,772
-125
| -2% | -$5.54K | ﹤0.01% | 1467 |
|
|
2022
Q2 | $255K | Sell |
6,897
-3,396
| -33% | -$126K | ﹤0.01% | 1610 |
|
|
2022
Q1 | $381K | Sell |
10,293
-1,063
| -9% | -$39.3K | ﹤0.01% | 1527 |
|
|
2021
Q4 | $346K | Buy |
11,356
+2,407
| +27% | +$73.3K | ﹤0.01% | 1608 |
|
|
2021
Q3 | $300K | Buy |
8,949
+1,553
| +21% | +$52.1K | ﹤0.01% | 1666 |
|
|
2021
Q2 | $295K | Buy |
7,396
+369
| +5% | +$14.7K | ﹤0.01% | 1577 |
|
|
2021
Q1 | $316K | Buy |
+7,027
| New | +$316K | ﹤0.01% | 1502 |
|
|
2020
Q3 | – | Sell |
-4,175
| Closed | -$246K | – | 1530 |
|
|
2020
Q2 | $246K | Sell |
4,175
-1,384
| -25% | -$81.5K | ﹤0.01% | 1366 |
|
|
2020
Q1 | $263K | Buy |
5,559
+145
| +3% | +$6.86K | ﹤0.01% | 1242 |
|
|
2019
Q4 | $327K | Sell |
5,414
-427
| -7% | -$25.8K | ﹤0.01% | 1294 |
|
|
2019
Q3 | $350K | Buy |
5,841
+17
| +0.3% | +$1.02K | ﹤0.01% | 1274 |
|
|
2019
Q2 | $375K | Buy |
5,824
+2,737
| +89% | +$176K | ﹤0.01% | 1274 |
|
|
2019
Q1 | $251K | Buy |
+3,087
| New | +$251K | ﹤0.01% | 1191 |
|